IceCure Medical Ltd. (ICCM) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and thank you for standing by. Currently, all the participants are in a listen-only mode. After management's discussion, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Michael Poliview. Please go ahead. Thank you, Yanni, and welcome to iSecure Medical's conference call to review the financial results as of and for the three months ended March 31, 2025, and provide an update on recent operational highlights. You may refer to Ernie's press release that we issued earlier this morning. Participating on today's call are iSecure Medical's CEO, Al Shamer, and company CFO and COO, Ronan Zimmerman. Before we begin, I will now take a moment to read a statement about forward-looking statements. This call and the question and answer section that follows it contain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Words such as expects, anticipates, intends, plans, believes, seeks, estimates, and similar expressions or variations of such words are intended to identify forward-looking statements. For example, we are using forward-looking statements in this presentation when we discuss a prospective post-market study plan and our beliefs and expectations following our meeting with the FDA at the end of April. The expectation of the FDA's final marketing authorization decision will present upon approval of the post-market study plan or plan to commence commercial sales in parallel with running our post-market study. Our belief that additional reimbursements may become available based on regulatory approval and are potential catalysts for the rest of...